1068P Phase II trial of fecal microbiota transplantation (FMT) plus immune checkpoint inhibition (ICI) in advanced non-small cell lung cancer and cutaneous melanoma (FMT-LUMINate)
Arielle Elkrief, Siddhartha P. Duttagupta, R. Jamal, Nicolas Marcoux, Antoine Desîlets, Meriem Messaoudene, Catalin Mihalcioiu, Sylvère Durand, M. Tehfe, N. Blais, Sioned Owen, J. Raphael, John Lenehan, Seema Nair Parvathy, L. Derosa, L. Zitvogel, Guido Guido Kroemer, Michael H. Silverman, Saman Maleki Vareki, Bertrand Routy (2024). 1068P Phase II trial of fecal microbiota transplantation (FMT) plus immune checkpoint inhibition (ICI) in advanced non-small cell lung cancer and cutaneous melanoma (FMT-LUMINate). , 35, DOI: https://doi.org/10.1016/j.annonc.2024.08.1126.
